The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immix Biopharma Inc shares valued at $5,050 were purchased by Rachman Ilya M on Sep 17 ’25. At $2.02 per share, Rachman Ilya M acquired 2,500 shares. The insider’s holdings grew to 1,140,937 shares worth approximately $4.24 million following the completion of this transaction.
Also, Morris Gabriel S purchased 2,600 shares, netting a total of over 5,122 in proceeds. Following the buying of shares at $1.97 each, the insider now holds 290,659 shares.
Before that, Rachman Ilya M had added 2,178 shares to its account. In a trade valued at $4,999, the CEO and Chairman bought Immix Biopharma Inc shares for $2.29 each. Upon closing the transaction, the insider’s holdings increased to 2,178 shares, worth approximately $4.23 million.
Analyzing IMMX Stock Performance
On last trading session, Immix Biopharma Inc [NASDAQ: IMMX] plunged -4.62% to $3.72. The stock’s lowest price that day was $3.6, but it reached a high of $3.924 in the same session. During the last five days, there has been a surge of approximately 20.39%. Over the course of the year, Immix Biopharma Inc shares have jumped approximately 124.10%. Shares of the company reached a 52-week high of $4.00 on 10/28/25 and a 52-week low of $1.34 on 04/08/25.
Support And Resistance Levels for Immix Biopharma Inc (IMMX)
According to the 24-hour chart, there is a support level at 3.57, which, if violated, would cause prices to drop to 3.42. In the upper region, resistance lies at 3.90. The next price resistance is at 4.07. RSI (Relative Strength Index) is 72.04 on the 14-day chart, showing overbought technical sentiment.
Is Immix Biopharma Inc subject to short interest?
Stocks of Immix Biopharma Inc saw a sharp rise in short interest on 2025-10-15 jumping by 0.14 million shares to 0.6 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 0.45 million shares. A jump of 24.05% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.51 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.51.
Which companies own the most shares of Immix Biopharma Inc (IMMX)?
In terms of Immix Biopharma Inc share price expectations, FactSet research, analysts set an average price target of 7 in the next 12 months, up nearly 79.49% from the previous closing price of $3.9. Analysts anticipate Immix Biopharma Inc stock to reach 7 by 2025, with the lowest price target being 7. In spite of this, 1 analysts ranked Immix Biopharma Inc stock as Buy at the end of 2025.
